Here are relevant reports on : oil-companies
-
Neurological Biomarkers Market by Offering (Consumables, Instruments), Type (Proteomic, Genomic), Application (Alzheimer’s, Parkinson’s), End user (Pharma Companies, Clinical Labs) - Forecast to 2030
The neurological biomarkers market, valued at USD 5.16 billion in 2024, stood at USD 5.53 billion in 2025 and is projected to advance at a resilient CAGR of 10.7% from 2025 to 2030, culminating in a forecasted valuation of USD 9.19 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Hydrogen Peroxide De-Contamination Market by Product & Services (Equipment, Consumables, Services), Type (Chamber, Room), End User (Pharma & Medical Device Manufacturing Companies, LifeSciences & Biotech Research Organizations, Hospitals & Healthcare Facilities) - Global Forecast to 2027
The global Hydrogen Peroxide De-Contamination market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Die Bonder Equipment Market by Type (Semiautomatic Die Bonder, Fully Automatic Die Bonder), Bonding Technique, Supply Chain Participant (IDM Firms, OSAT Companies), Device, Application (Consumer Electronics), and Region - Global Forecast to 2024
The Die Bonder Equipment Market is expected to grow from USD 820 million in 2019 to USD 972 million by 2024, at a CAGR of 3.5% during the forecast period. BE Semiconductor Industries N.V. (Netherlands), ASM Pacific Technology Ltd. (Singapore), Kulicke & Soffa (Singapore), Mycronic AB (Sweden), Palomar Technologies, Inc. (US), West·Bond, Inc. (US), MicroAssembly Technologies, Ltd. (Israel), Finetech GmbH & Co. KG (Germany), Dr. Tresky AG (Switzerland), Smart Equipment Technology (France) are the key players in the die bonder equipment market. These players are increasingly undertaking strategies such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions to increase their market share.
- Published: November 2019
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Sterilization Monitoring Market by Technology (Biological, Chemical), Product (Self-contained Vials, Integrating, Emulating & Bowie-dick Indicators), Method (Steam, EtO), Process (Pack, Load), End User (Hospitals, Pharma Companies) - Global Forecast to 2022
The sterilization monitoring market is expected to reach USD 631.0 Million by 2022 from USD 439.5 million in 2017, at a CAGR of 7.5% between 2017 and 2022. Factors such as rising incidence of hospital-acquired infections, increasing number of surgical procedures coupled with the rising geriatric population and chronic disease incidence, technological advancements in sterilization monitoring products, and rising focus on food sterilization are the major factors driving the growth of this market.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027
The global Antigen and Antibodies Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing proteomics and genomics research, massive use of antigen and antibodies in the vaccine development, drug discovery, disease study and diagnosis.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Hydrophobic Interaction Chromatography Market by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes) - Global Forecast to 2023
The global hydrophobic interaction chromatography market is projected to reach USD 418.2 million in 2023 from USD 271.0 million in 2017, at a CAGR of 7.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, there is a growing demand for hydrophobic interaction chromatography. The major factors driving the growth of this market are the increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals. The key players in the global hydrophobic interaction chromatography market are GE Healthcare (US), Bio-Rad Laboratories (US), Sartorius (Germany), and Thermo Fisher Scientific (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Cell Culture Equipment Market by Type (Supporting, Bioreactors, Storage), Application (Biopharma Production, Diagnostics, Tissue Engineering), End User (Pharma & Biotech Companies, Hospitals & Diagnostic Labs, Academia), Region - Global Forecast to 2031
The Cell Culture Equipment market, valued at USD 7.77 billion in 2025, stood at USD 8.36 billion in 2026 and is projected to advance at a resilient CAGR of 11.1% from 2026 to 2031, culminating in a forecasted valuation of USD 14.18 billion by the end of the period. Cell culture equipment encompasses the instruments used to grow and maintain cells in controlled laboratory environments for medical, research, and production purposes.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Deoxynucleoside Triphosphates Market by Type (Solid, Liquid dNTPs), End User (Research Institutes, Biotech & Pharmaceutical Companies)-Global Forecast to 2027
The global Deoxynucleoside triphosphates market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
